Results 81 to 90 of about 25,725 (245)

Conquering the pneumococcal nemesis with oral antibiotics

Journal of Community Hospital Internal Medicine Perspectives, 2020
Introduction Streptococcus pneumoniae endocarditis (SPE) occurs in
Rana Garris, Rushdy Abanoub, Firas Qaqa, Chirag Rana, Nirmal Guragai, Habib A. Habib, Fayez Shamoon, Mahesh Bikkina   +7 more
doaj   +1 more source

Oral Health, Periodontitis, and Respiratory Diseases: Biological Pathways

Journal of Periodontal Research, EarlyView.
This narrative review aims to provide a comprehensive update on the potential mechanisms by which poor oral health and periodontitis impact lung health, focusing on pneumonia, COPD, and asthma. ABSTRACT Poor oral hygiene and periodontitis influence lung diseases such as pneumonia, chronic obstructive pulmonary disease (COPD), COVID‐19, and asthma.
Raluca P. Vacaru, Andreea C. Didilescu, Frank A. Scannapieco   +2 more
wiley   +1 more source

Health and Survival Impacts of Early Childhood Development Programmes: The Case of the Happy Child Programme in Brazil

Review of Development Economics, EarlyView.
ABSTRACT This paper adds to the growing evidence on the impacts of early childhood development (ECD) programming by examining one of the world's largest home visitation programmes, the Happy Child Programme in Brazil, and its impacts on child vaccination and preventable death rates.
Raquel Tebaldi, Franziska Gassmann, Bruno Martorano   +2 more
wiley   +1 more source

Data_Sheet_1_Global transcriptional responses of pneumococcus to human blood components and cerebrospinal fluid.PDF

, 2022
Streptococcus pneumoniae (pneumococcus) is a leading cause of severe invasive infectious diseases such as sepsis and meningitis. Understanding how pneumococcus adapts and survive in the human bloodstream environment and cerebrospinal fluid (CSF) is ...
Jakob Møller-Jensen (231833), Frida Fabricius Høg (14287334), Flemming Damgaard Nielsen (8532720), Jens Sivkær Pettersen (14287331), Mikkel Girke Jørgensen (8532726)   +4 more
core   +1 more source

Roles of Complement C1q in Pneumococcus-Host Interactions

, 2015
The fight between a human host and a bacterial pathogen is highly complicated; each party tries to outshine the other in the race for survival. In humans, the innate immune system-in particular the complement system-functions as the first line of defence
Blom, Anna,, Lund University., Agarwal, Vaibhav   +2 more
core   +2 more sources

Mast Cells in Acute COVID‐19 Patients

Allergy, EarlyView.
Ilan Zaffran, Hadas Pahima, Eli Ben‐Chetrit, Amir Jarjoui, Ilaria Puxeddu, Carl Zinner, Joana Vitte, Alexandar Tzankov, Francesca Levi‐Schaffer   +8 more
wiley   +1 more source

Access to Safety Net Programs in the U.S. During the COVID‐19 Pandemic: Barriers and Lessons From a Scoping Review

Social Policy &Administration, EarlyView.
ABSTRACT The COVID‐19 pandemic triggered historic expansions of the U.S. social safety net to mitigate unprecedented economic hardship. However, increased government spending and program expansions on paper do not automatically translate into equitable access in practice.
Soohyun Yoon, Jeehae Kang
wiley   +1 more source

Pneumococcus: the sugar-coated bacterium

, 2010
The study of Streptococcus pneumoniae (the pneumococcus) had been a central issue in medicine for many decades until the use of antibiotics became generalized.
López, Rubens
core  

Identification of pneumococcal serotypes with individual recognition of vaccine types by a highly multiplexed real-time PCR-based MeltArray approach

Journal of Microbiology, Immunology and Infection
Background: Pneumococcus serotyping is important for monitoring serotype epidemiology, vaccine-induced serotypes replacement and emerging pathogenic serotypes.
Shujuan Zhou, Jie Che, Xuran Wang, Yong Lin, Jianjun Niu, Weitong Liang, Li Xu, Maojun Zhang, Yiqun Liao, Zhujun Shao, Qingge Li   +10 more
doaj   +1 more source

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real‐World International Experience

American Journal of Hematology, Volume 101, Issue 7, Page 1597-1604, July 2026.
ABSTRACT Sutimlimab is a monoclonal antibody against complement fraction C1s approved for the treatment of hemolytic anemia due to cold agglutinin disease (CAD). Here, we analyzed and report the largest international CAD cohort of sutimlimab‐treated patients ever reported to highlight its safety and effectiveness in the real‐world setting. We accrued a
Bruno Fattizzo, Elisa Sambruna, Yoshitaka Miyakawa, Marc Michel, Carlo Visco, Michael Fillitz, George Kannourakis, Maria Bruna Greve, Moritz Kleemiss, Johan Cid, Andrea Patriarca, Laura Pavan, Arbana Dizdari, Nilla Maschio, Antonella Sau, Cinzia Bitetti, Riccardo Mario Colombo, Luigi Curreli, Dorela Lame, Uros Markovic, Fabrizio Pappagallo, Giacinto Luca Pedone, Davide Rapezzi, Vincenzo Sammartano, Nicola Tumedei, Antonio Giovanni Solimando, Jalink Marit, Luana Fianchi, Jahanzaib Khwaja, Antonio De Vivo, Francesco Lanza, Fabrizio Vianello, Esther N. Oliva, Catherine Broome, Francesco Passamonti, Ulrich Jaeger, Bernd Jilma, Guillaume Moulis, Wilma Barcellini   +38 more
wiley   +1 more source